Effect of the organic calcium antagonist D-600 on cerebrocortical vascular and redox responses evoked by adenosine, anoxia, and epilepsy.
D000241:Adenosine / Q000494:pharmacology*; D000818:Animals; D001810:Blood Volume / Q000187:drug effects; D002415:Cats; D002540:Cerebral Cortex / Q000187:drug effects; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D004562:Electrocardiography; D005711:Gallopamil / Q000494:pharmacology*; D000860:Hypoxia / Q000503:physiopathology*; D008297:Male; D009243:NAD / Q000378:metabolism; D010084:Oxidation-Reduction / Q000187:drug effects*; D012640:Seizures / Q000503:physiopathology*; D014700:Verapamil / Q000031:analogs & derivatives*
D009243:NAD; D005711:Gallopamil; D014700:Verapamil; D000241:Adenosine